174
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Correlation of nuchal translucency and thyroxine at 11–13 weeks of gestation

, , , , , , , , , , & show all
Pages 1586-1589 | Received 04 Jan 2013, Accepted 07 Mar 2013, Published online: 17 Apr 2013

References

  • Nicolaides KH, Heath V, Cicero S. Increased fetal nuchal translucency at 11–14 weeks. Prenat Diagn 2002;22:308–15
  • Cullen MT, Gabrielli S, Green JJ, et al. Diagnosis and significance of cystic hygroma in the first trimester. Prenat Diagn 1990;10:643–51
  • Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992;304:867–9
  • Bahado-Singh RO, Wapner R, Thom E, et al. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol 2005;192:1357–61
  • Ngo C, Viot G, Aubry MC, et al. First-trimester ultrasound diagnosis of skeletal dysplasia associated with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2007;30:221–6
  • von Kaisenberg CS, Wilting J, Dork T, et al. Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: comparison with trisomies and controls. Mol Human Reprod 2010;16:778–89
  • Kagan KO, Wright D, Valencia C, et al. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 2008;23:1968–75
  • Jou HJ, Wu SC, Li TC, et al. Relationship between fetal nuchal translucency and crown–rump length in an Asian population. Ultrasound Obstet Gynecol 2001;17:111–14
  • Cowans NJ, Stamatopoulou A, Maiz N, et al. The impact of fetal gender on first trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A MoM in normal and trisomy 21 pregnancies. Prenat Diagn 2009;29:578–81
  • Weissmann-Brenner A, Weisz B, Lerner-Geva L, et al. Increased nuchal translucency is associated with large for gestational age neonates in singleton pregnancies. J Perinat Med 2011;39:305–9
  • Spencer K, Ong CY, Liao AW, Nicolaides KH. The influence of parity and gravidity on first trimester markers of chromosomal abnormality. Prenat Diagn 2000;20:792–4
  • Ashoor G, Kametas NA, Akolekar R, et al. Maternal thyroid function at 11–13 weeks of gestation. Fetal Diagn Ther 2010;27:156–63
  • Maymon R, Padoa A, Dreazen E, et al. Nuchal translucency measurements in consecutive normal pregnancies. Is there a predisposition to increased levels? Prenat Diagn 2002;22:759–62
  • Safer JD. Thyroid hormone action on skin. Dermatoendocrinol 2011;3:211–15
  • Huel C, Guibourdenche J, Vuillard E, et al. Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter. Ultrasound Obstet Gynecol 2009;33:412–20
  • Stewart CJ, Constantatos S, Joolay Y, Muller L. In utero treatment of fetal goitrous hypothyroidism in a euthyroid mother: a case report. J Clin Ultrasound 2012;40:603–6
  • Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation. Lancet 1998;352:343–6
  • Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008;112:85–92
  • Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526–34
  • Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000;7:127–30
  • Ashoor G, Rotas M, Maiz N, et al. Maternal thyroid function at 11–13 weeks of gestation in women with hypothyroidism treated by thyroxine. Fetal Diagn Ther 2010;28:22–7
  • Calvo RM, Jauniaux E, Gulbis B, et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 2002;87:1768–77
  • Li Y, Shan Z, Teng W, et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25–30 months. Clin Endocrinol (Oxf) 2010;72:825–9
  • Wang S, Teng WP, Li JX, et al. Effects of maternal subclinical hypothyroidism on obstetrical outcomes during early pregnancy. J Endocrinol Invest 2012;35:322–5
  • Bohlandt S, von Kaisenberg CS, Wewetzer K, et al. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod 2000;15:1155–8
  • Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004;351:241–9
  • Glinoer D, De Nayer P, Robyn C, et al. Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest 1993;16:881–8
  • Souka AP, Von Kaisenberg CS, Hyett JA, et al. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005;192:1005–21
  • Ashoor G, Maiz N, Cuckle H, et al. Maternal thyroid function at 11–13 weeks of gestation in fetal trisomies 21 and 18. Prenat Diagn 2011;31:33–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.